This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
AF1Q monoclonal antibody (M01), clone 2A9-1B7
catalog :
H00010962-M01
quantity :
100 ug
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
reactivity :
human
application :
western blot, ELISA
citations: 4
| Reference |
|---|
Chang X, Li D, Hou Y, Wu J, Lu J, Di G, et al. Identification of the functional role of AF1Q in the progression of breast cancer. Breast Cancer Res Treat. 2008;111:65-78 pubmed
|
product information
catalog id :
H00010962-M01
product name :
AF1Q monoclonal antibody (M01), clone 2A9-1B7
product description :
Mouse monoclonal antibody raised against a full length recombinant AF1Q.
clone name :
2A9-1B7
isotype :
IgG2a kappa
gene name :
MLLT11
gene alias :
AF1Q RP11-316M1.10
gene description :
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
genbank accession :
BC009624
immunogen :
AF1Q (AAH09624, 1 a.a. ~ 90 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
immunogen sequence protein sequence :
MRDPVSSQYSSFLFWRMPIPELDLSELEGLGLSDTATYK
VKDSSVGKMIGQATAADQEKNPEGDGLLEYSTFNFWRAP
IASIHSFELDLL
VKDSSVGKMIGQATAADQEKNPEGDGLLEYSTFNFWRAP
IASIHSFELDLL
protein accession :
AAH09624
storage buffer :
In 1x PBS, pH 7.4
storage instruction :
Store at -20 C or lower. Aliquot to avoid repeated freezing and thawing
quality control testing :
Antibody Reactive Against Recombinant Protein
type clonality :
Antibody
raised in host species :
Mouse
antigen species target species :
Human
species reactivity cross reactivity :
Human
application key :
S-ELISA,ELISA,WB-Re
size :
100 ug
autodate :
10/17/06
updatetime :
11/15/13 18:37
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments
